Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
about
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGFTGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysisEssential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.Cardiovascular aging research: the next horizons.Protein kinase C delta mediates arterial injury responses through regulation of vascular smooth muscle cell apoptosis.TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.Ascending thoracic aortic aneurysms protect against myocardial infarctionsThe periodontal pathogen Porphyromonas gingivalis changes the gene expression in vascular smooth muscle cells involving the TGFbeta/Notch signalling pathway and increased cell proliferationp75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells.Role of elevated plasma transforming growth factor-beta1 levels in wound healing.Transforming growth factor-β and smooth muscle differentiationCD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombinationFibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels.Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formationCell Growth of BG-1 Ovarian Cancer Cells was Promoted by 4-Tert-octylphenol and 4-Nonylphenol via Downregulation of TGF-β Receptor 2 and Upregulation of c-myc.Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome.Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic EffectsCholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line.A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation.Cell volume and rate of proliferation, but not protein expression pattern, distinguish pup/intimal smooth muscle cells from subcultured adult smooth muscle cells.TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress?Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).Local Stent-Based Release of Transforming Growth Factor-β1 Limits Arterial In-Stent Restenosis.Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.
P2860
Q28582555-D368AAB8-2321-481B-9AEC-FC1F9B8D04BEQ28712812-98E90003-B74F-48B5-AC16-09CDBA131D2FQ33393631-B149CE7E-25DA-4966-A529-7E45D3B66BDFQ33633405-97F1DE9E-155B-4731-9CDD-DDD2240D174DQ33814834-59600D5D-D468-40B9-A57D-1044B7EB6EF6Q34007727-F825C55F-72C2-4038-8F34-EC41B5A0A73FQ34213083-475AD088-A146-47BD-8D3A-71E58C731F64Q35037649-CAD2F95F-B345-480B-BD9D-E76176079BD2Q35745844-7CF5F7A1-4225-4619-8809-1A38D3B5F27CQ35786858-2A98310B-02B1-4A40-94BD-2D0C015FCA05Q35852389-B3BA19B4-CC01-46DA-9C28-B22571B1502AQ36243258-1DF4524C-C9AA-4886-A484-E4BA80293479Q36320690-46911937-8898-4B2E-86AA-98B2E935A28AQ36524547-06F8C34C-EDD1-49DC-9B54-999353239618Q37298372-9E7B46C6-E1E1-4194-AE31-3613C4BE2D45Q37326299-AB44C693-6582-441D-8297-A7A2351B16A4Q37374163-97E96332-4393-44FD-BA7A-D49353758651Q37388115-0A734AD7-079E-46C7-A768-F637A0D620AFQ37406279-8FD00703-F57F-4D3E-895E-398314711698Q37427183-E907D9CD-75AB-424A-8E96-24F1E90A5448Q37882523-2EE16B79-260C-416D-8891-529AB68A38E8Q38314798-43769D9A-E42D-4531-AFA2-7EB5E08F9C69Q38958854-3818B644-3AD6-45BF-A5A5-DDCB1295C084Q40059690-DF25761C-3216-4B50-9D52-EF27D6B7832BQ41060120-086E4AC7-1F56-49A9-A58D-698E8BACBA62Q42653520-3E399086-7707-4309-94A1-62C984D5DA5FQ42824861-13FA7DB9-A47B-4BD7-8774-33FBFB1945BFQ44129279-EDB56AA1-64B8-4EBF-9C8A-C2BEF58069ACQ48824445-53850779-36CB-4E9C-B13F-66C433E66924Q50539676-9D1E8DC4-C265-4F0F-8D8D-9D4ECD62E9CCQ51318688-4C827908-25AA-4A11-92D7-882AE0780A34Q51687284-00A217ED-CE70-4BC0-92A4-059FC8DCC559Q53956224-4EEC683E-B693-488B-AFE4-13E15BFB76ABQ54037308-BF8AF0CE-41DD-470C-9DA9-D8D1E1AD5D02
P2860
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@ast
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@en
type
label
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@ast
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@en
prefLabel
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@ast
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@en
P2093
P2860
P356
P1476
Decreased type II/type I TGF-b ...... ibrotic response to TGF-beta1.
@en
P2093
A M Spokojny
D J Falcone
S Consigli
T A McCaffrey
T A Sanborn
P2860
P304
P356
10.1172/JCI118333
P407
P577
1995-12-01T00:00:00Z